Wei Dong

8.7k citations
233 papers · 7k · 1 hit paper · h-index 42

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
  • Hepatology top 2%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • MicroRNA in disease regulation 17
    • Hepatocellular Carcinoma Treatment and Prognosis 13
    • Liver physiology and pathology 8

Wei Dong

224 papers receiving 6.9k citations

Wei Dong's Hit Papers

N6-Methyladenosine–Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells’ Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways 2023 · 219 citations
2190+1+2Years since publication50100150200

Peers

Wei Dong
Comparison fields: 5 of 140
  • Cancer Research 1.2k
  • Hepatology 449
  • Molecular Biology 2.4k
  • Nephrology 329
  • Parasitology 206
Replace Hui Fen Dong with:
Hui Fen Dong China
Pedro R. Cutillas United Kingdom
Jing Liu China
Xian Wang China
Wenjie Wang China
Lifu Wang China
Jian Liu China
Limin Liu China
Heinfried H. Radeke Germany
Fang Wang China
Wei Dong relative to Hui Fen Dong China Hui Fen Dong's profile →
Citations per field
00.5×2×2.9×
Hui Fen Dong · 1×
Citations per year

Countries citing papers authored by Wei Dong

Since Specialization
Citations

This map shows the geographic impact of Wei Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Dong more than expected).

Fields of papers citing papers by Wei Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Dong. The network helps show where Wei Dong may publish in the future.

Co-authors

The 25 scholars most cited alongside Wei Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wei Dong Line = papers co-authored together Wei Dong links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 233 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2014374
2 2010305
3 2013226
4
N6-Methyladenosine–Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells’ Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways
Hit paper breakdown →
2023219
5 2012205
6 2013146
7 2019141
8 2018139
9 2020137
10 2019136
11 2011129
12 2019125
13 2012123
14 2015116
15 2018104
16 201687
17 201983
18 201975
19 201771
20 201667

About Wei Dong

Wei Dong is a scholar working on Cancer Research, Hepatology, Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, having authored 233 papers that have together received 7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (17 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Lung Cancer Research Studies (13 papers), Plant Stress Responses and Tolerance (10 papers), Circular RNAs in diseases (10 papers), Liver physiology and pathology (8 papers), Cancer Cells and Metastasis (7 papers) and Ferroptosis and cancer prognosis (7 papers). The work is most often cited by research in Cancer Research (1.2k citations), Hepatology (449 citations), Molecular Biology (2.4k citations), Nephrology (329 citations) and Parasitology (206 citations). Wei Dong has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Tianxin Lin, Hongchang Shen, Jiajun Du, Junming Bi, Jian Huang, Guangmin Xia, Mengcheng Wang, Meihua Yang, Langtao Xiao and Tiehong Zhang. Their work appears in journals such as Scientific Reports, Cancer Letters, Oncology Reports, Aging and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact